In Depth 10 Feb 2025
Monoclonal antibodies: are they the key to treating Alzheimer’s disease?
A major stride in treating Alzheimer’s disease has been the development of monoclonal antibodies.
- Latest Posts
Partnering 2030: FME Industries Report
Download Inpart’s new report to discover key challenges in the Food, Material, and Electromechanical (FME) industries, the best channels for sourcing new partners, and a ranking of the top companies in industry-academia partnerships.
Podcast 7 Feb 2025
Targeting the dark genome to develop new therapies to fight obesity
This week, our podcast guest is Samir Ounzain, CEO of Haya Therapeutics. Ounzain was one of the first researchers to publish on lncRNA, also known as the ‘dark genome.’
News and Trends 6 Feb 2025
Top biotech deals of January 2025
January 2025 kicked off in full swing with several biotech deals in the biopharma industry.
In Depth 5 Feb 2025
Needle-free vaccines: Micron Biomedical, Vaxxas, and IntegriMedical bring their new technologies to patients
Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in this space.
In Depth 4 Feb 2025
World Cancer Day: trends in cancer therapeutics to look forward to in 2025
As we observe World Cancer Day today, let us look at some of the trends in cancer therapeutics expected to improve cancer care in 2025.
ADVERTISEMENT
ADVERTISEMENT
News and Trends 4 Feb 2025
Akribion Therapeutics emerges from stealth with programmable cell depletion RNA technology
Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach
In Depth 3 Feb 2025
The biggest biotech funding rounds in January 2025
The companies Immunovant, Verdiva Bio, and Akero Therapeutics bagged the biggest biotech funding rounds overall in January 2025.
News and Trends 31 Jan 2025
U.K. biotech defies the odds, raising £3.5B in 2024
The U.K. biotech sector raised £3.5 billion in equity financing last year amid challenges, according to a BIA report.
Podcast 31 Jan 2025
Can tumor activated therapy kill solid tumors?
Solid tumors are a big challenge. However, a new approach might provide the answer – tumor-activated Therapy. We discuss this with Seekyo Therapeutics’ CEO, Oury Chetboun
Best in Biotech 30 Jan 2025
Seven genome sequencing companies to look out for
There are a number of genomics startups that have sprouted up to strengthen their sequencing technologies to aid in disease prevention and treatment.
In Depth 29 Jan 2025
Pancreatic cancer: Oncolytics Biotech, Candel, and CytomX bring promising therapies to the clinic
Discover the treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to treat.
ADVERTISEMENT
